PLA2G7 and hepatocellular carcinoma: Notably, the immunosuppressive PLA2G7high macrophages impeded CD8 T-cell function, and inhibition of PLA2G7 by darapladib enhanced the efficacy of anti-PD-1 antibody immunotherapy in hepatocellular carcinoma (HCC) mouse models [20].